preDQ - Update & Upgrade Update and maintenance of the preDQ - software tool for peptide binding prediction to HLA-DQ2 and HLA-DQ8
preDQ is a software tool for prediction of peptides binding to HLA‐DQ2 and HLA‐DQ8 proteins, associated with susceptibility to celiac disease. preDQ was designed to evaluate the risk of novel proteins to cause celiac disease following EFSA's guidance on assessment of genetically modified plants. The predictive capability of preDQ relies on the utilization of five robust models, each producing five corresponding risk assessment outputs. These models have been developed using datasets containing both known binding and non‐binding peptides to HLA‐DQ2.5 and HLA‐DQ8.1.
Read the official notice →Source: EFSA (European Food Safety Authority) · EFSA reuse policy (attribution). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.
More from European Union
- Plant Health Newsletter on HORIZON SCANNING June 2026 regulatory
- 2025 EFSA Annual Report Emerging Risks and Horizon Scanning Activities regulatory
- Safety evaluation of an extension of use of the food enzyme α-amylase from the non-genetically modified Bacillus amyloliquefaciens strain LMG-S 32676 regulatory
- Safety evaluation of an extension of use of the food enzyme α-amylase from the genetically modified Aspergillus niger strain NZYM-SB regulatory
- Safety evaluation of an extension of use of the food enzyme phospholipase A1 from the genetically modified Aspergillus niger strain NZYM-FP regulatory
- Safety evaluation of an extension of use of the food enzyme phospholipase A1 from the genetically modified Aspergillus oryzae strain NZYM-PP regulatory
What this means for your label
A notice like this changes what a pack must carry. These are the rules we build against, starting with EU 1169.